XIST and breast cancer: We next explored the cellular pathway(s) of cell viability regulated by Xist. Since both RAS/ERK and PI3K/AKT pathways are the most frequently dysregulated signaling pathways associated with breast cancer cell growth and viability [16], we tested whether alteration of Xist levels modulated both pathways in breast cells.